Navigating Pharma Imports: Trade Compliance Insights with Elizabeth Lomax

We had the pleasure of speaking with Elizabeth Lomax 🌎 Trade Compliance Consultant, founder of Lomax Associates and trade compliance leader in the pharmaceutical sector.

We covered:
- Why classifying Active Pharmaceutical Ingredients can be so tricky
- The role of the FDA, DEA, USDA — and even Fish & Wildlife — in pharma imports
- What to know about the Section 232 investigation and potential new tariffs
- How small and mid-sized companies can improve compliance without massive systems
- Beth’s tips for building a trade compliance career in this space

Beth’s depth of knowledge and practical advice made this a fantastic conversation. We’re excited to share it with you.

🎧 Listen here: Spotify or on your preferred podcast platform.
‍

‍

Tags: Denied Party Screening; Restricted Party Screening; Import/Export Flags; Customs Flags and Classification; U.S. Harmonized Tariff Schedule (2025); U.S. Anti Dumping Duty Orders mapped to HS Codes; HTS Change Record; OFAC / SDN - Office of Foreign Assets Control - Specially Designated Nationals; HHS - List of Excluded Individuals/Entities (LEIE); Early Detection and Exclusion System (EDES); Ineligible Firms and Individuals